Wordt geladen...
Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry
Background: Moderate and high efficacy disease modifying therapies (DMTs) have a profound effect on disease activity. The current treatment guidelines only recommend high efficacy DMTs for patients with highly active MS. The objective was to examine the impact of initial treatment choice in achievin...
Bewaard in:
| Gepubliceerd in: | Front Neurol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248666/ https://ncbi.nlm.nih.gov/pubmed/34220694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.693017 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|